We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current 0QN1 market cap is 14.33B. The company's latest EPS is CHF -0.9436 and P/E is -12.40.
| Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| CHF (CHF) | CHF (CHF) | CHF (CHF) | CHF (CHF) | CHF (CHF) | |
| Total Revenue | 31.66M | 75.38M | 15.01M | -1.6M | 7.47M |
| Operating Income | -51.42M | -10.44M | -53.08M | -56.89M | -51.98M |
| Net Income | -54.19M | -18.97M | -67.66M | -55.53M | -71.08M |
| Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| CHF (CHF) | CHF (CHF) | CHF (CHF) | CHF (CHF) | CHF (CHF) | |
| Total Assets | 110.29M | 115.05M | 88.69M | 91.12M | 63.73M |
| Total Liabilities | 82.47M | 93.8M | 95.04M | 89.79M | 107.41M |
| Total Equity | 27.83M | 21.25M | -6.35M | 1.33M | -43.69M |
| Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| CHF (CHF) | CHF (CHF) | CHF (CHF) | CHF (CHF) | CHF (CHF) | |
| Operating | -37.87M | 2.6M | -43.51M | -37.36M | -29.84M |
| Investing | -5.91M | 2.79M | 1.56M | 69k | -3.93M |
| Financing | 20.64M | 4.13M | 23.15M | 46.02M | 13.99M |
| Market Cap | 14.33B |
| Price to Earnings Ratio | -12.40 |
| Price to Sales Ratio | 117.94 |
| Price to Cash Ratio | 650 |
| Price to Book Ratio | -20.17 |
| Dividend Yield | - |
| Shares Outstanding | 75.32M |
| Average Volume (1 week) | 828 |
| Average Volume (1 Month) | 788 |
| 52 Week Change | 0.00% |
| 52 Week High | 190.20 |
| 52 Week Low | 190.20 |
| Spread (Intraday) | 0 (0%) |
| Company Name | Santhera Pharmaceuticals Holding Ag |
| Address |
hammerstrasse 49 liestal 4410 |
| Website | https://www.santhera.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
